Background illustration for clinical trials search

Paid Clinical Trials Montreal

Discover 1,169 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Montreal, Ottawa, Quebec, Kingston, Oshawa, Newmarket,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06182774

Phase 3, Recruiting

Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency

for
Limbal Stem Cell Deficiency
Location: Montreal, Quebec, Toronto
Sponsor: CHU de Quebec-Universite Laval

Sex: All

Age: 1+

Code: NCT01756365

Recruiting

Conduction System Pacing With Left Bundle Branch Pacing as Compared to Standard Right Ventricular Pacing

for
Pacemaker DDD, Heart Block
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT05015660

Recruiting

COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases

for
Rheumatoid Arthritis, Autoimmune Rheumatologic Disease,
Location: Montreal, Quebec
Sponsor: Paul R Fortin

Sex: All

Age: 18+

Code: NCT05236491

Phase 2, Phase 3, Recruiting

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

for
Weight Management
Location: Montreal, Saint-Lambert, Terrebonne, Joliette,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07667803

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

for
Clostridioides Difficile Infection
Location: Montreal, Sherbrooke, Quebec, Boston MA, Hamden CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07285213

Phase 2, Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Montreal, Toronto
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07491445

Phase 3, Recruiting

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

for
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor,
Location: Montreal, Toronto, Charlottesville VA, Columbus OH,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT07165132

Phase 1, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for
Solid Tumors
Location: Montreal, Quebec, Boston MA, Toronto, Hackensack NJ,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase 3, Recruiting

Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis

for
ESRD, CKD (Chronic Kidney Disease) Stage 5D
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT06913647

Phase 2, Recruiting

Analysis of Inflammatory Biomarker Changes in Dry Blood Spot Versus Venous Blood Samples

for
Inflammation, Inflammation Biomarkers, Blood Sampling,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT07435285

Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Montreal, Ottawa, Quebec, Barrie, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Montreal, Lebanon NH, Boston MA, Rochester NY,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07097142

Phase 3, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Montreal, Quebec, Hartford CT, Providence RI,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase 3, Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

for
Progressive Pulmonary Fibrosis,
Location: Montreal, Trois-Rivieres, Farmington CT, New Haven CT,
Sponsor: Avalyn Pharma Inc.

Sex: All

Age: 18+

Code: NCT06951217

Phase 2, Recruiting

A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

for
Chronic Spontaneous Urticaria
Location: Montreal, Ottawa, Quebec, Niagara Falls, The Bronx NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07219615

Phase 2, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Montreal, Burlington VT, Lebanon NH, Syracuse NY,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase 3, Recruiting

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

for
Type 2 Diabetes Mellitus
Location: Montreal, Saint-Charles-Borromee, Stouffville,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07662213

Phase 3, Recruiting

People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk

for
Osteoporosis
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 70+

Code: NCT07621679

Recruiting

This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65.

for
Muscle, Cognitive Functioning, Geriatric,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 65+

Code: NCT07419633

Recruiting